Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ACACB | O00763 | 1/20 | 0.31 |
| ▸ | ACACA | Q13085 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19664763 | 1.00 | MEN1 (0.33) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL19664756 | 1.00 | MEN1 (0.33) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL19664739 | 1.00 | MEN1 (0.33) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL19664761 | 1.00 | MEN1 (0.33) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL19664747 | 1.00 | MEN1 (0.33) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL19664748 | 1.00 | MEN1 (0.33) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL19664753 | 1.00 | MEN1 (0.33) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL19664751 | 0.98 | LMNA (0.35) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL1436756 | 0.91 | MEN1 (0.39) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL25384623 | 0.84 | LMNA (0.37) | MEN1CYP3A4ALOX15KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4364861-A1 | AQUEOUS COATING MATERIAL COMPOSITION AND COATED ARTICLE USING SAME, AND MULTILAYER COATING FILM FORMING METHOD | Kansai Paint Co., Ltd (JP) | 2024-05-08 | — | — | EP | disclosed |
| CN-117580918-A | Aqueous coating composition, coated article using aqueous coating composition, and method for forming multilayer coating film | 关西涂料株式会社 | 2024-02-20 | — | — | CN | disclosed |
| US-20240024252-A1 | LIPID NANOPARTICLE | NITTO DENKO CORPORATION (JP) | 2024-01-25 | — | — | US | disclosed |
| WO-2024018762-A1 | PH-SENSITIVE CATIONIC LIPID AND LIPID NANOPARTICLE | 国立大学法人北海道大学 | 2024-01-25 | — | — | WO | disclosed |
| WO-2024018761-A1 | NEUTRAL LIPID AND LIPID NANOPARTICLE | 国立大学法人北海道大学 | 2024-01-25 | — | — | WO | disclosed |
| WO-2023191050-A1 | PHARMACEUTICAL COMPOSITION FOR DELIVERY TO CANCER, OR IMMUNOSTIMULATING COMPOSITION | 日東電工株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023188830-A1 | LIPID NANOPARTICLES | 国立大学法人北海道大学 | 2023-10-05 | — | — | WO | disclosed |
| EP-4223314-A1 | LIPID NANOPARTICLE | National University Corporation Hokkaido University (JP) | 2023-08-09 | — | — | EP | disclosed |
| CN-116367718-A | Lipid nanoparticles | 国立大学法人北海道大学 | 2023-06-30 | — | — | CN | disclosed |
| WO-2023276764-A1 | AQUEOUS COATING MATERIAL COMPOSITION AND COATED ARTICLE USING SAME, AND MULTILAYER COATING FILM FORMING METHOD | 関西ペイント株式会社 | 2023-01-05 | — | — | WO | disclosed |
| CN-107207894-B | Aqueous coating composition | 关西涂料株式会社 | 2020-09-04 | — | — | CN | disclosed |
| CN-107207891-B | Aqueous coating composition | 关西涂料株式会社 | 2020-09-04 | — | — | CN | disclosed |
| US-10639672-B2 | Method for forming multilayer coating film | KANSAI PAINT CO., LTD. (JP) | 2020-05-05 | — | — | US | disclosed |
| US-10508212-B2 | Method for forming multilayer coating film | KANSAI PAINT CO., LTD. (JP) | 2019-12-17 | — | — | US | disclosed |
| EP-3252118-B1 | AQUEOUS COATING COMPOSITION | KANSAI PAINT CO LTD (JP) | 2019-10-30 | — | — | EP | disclosed |
| US-20180021810-A1 | METHOD FOR FORMING MULTILAYER COATING FILM | KANSAI PAINT CO., LTD. (JP) | 2018-01-25 | — | — | US | disclosed |
| US-20180016462-A1 | METHOD FOR FORMING MULTILAYER COATING FILM | KANSAI PAINT CO., LTD. (JP) | 2018-01-18 | — | — | US | disclosed |
| US-20170369732-A1 | AQUEOUS COATING COMPOSITION | KANSAI PAINT CO., LTD. (JP) | 2017-12-28 | — | — | US | disclosed |
| US-20170355863-A1 | AQUEOUS COATING COMPOSITION | KANSAI PAINT CO., LTD. (JP) | 2017-12-14 | — | — | US | disclosed |
| EP-3252118-A1 | AQUEOUS COATING COMPOSITION | Kansai Paint Co., Ltd (JP) | 2017-12-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240024252-A1 | LIPID NANOPARTICLE | LIPC, ACOX1, ABCB4 | MEN1 3041/4885CYP3A4 1117/4885ALOX15 563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.